HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo

Clinical Immunology

Volumn 111, Issue 3, 2004, Pages 275-285

  Martin, Geneviève ^a   Tremblay, Michel J ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

CD40; CD40L; CD86; HIV 1; HLA DR; ICAM 1; Lymphoid tissue; PBMCs

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; EMBRYO; EX VIVO STUDY; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIFE CYCLE; LYMPHOID TISSUE; MACROPHAGE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGENY; RETROVIRUS INFECTION; T LYMPHOCYTE; TISSUE CULTURE; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD86; CD40 LIGAND; CELL LINE; FLOW CYTOMETRY; HIV-1; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; TONSIL;

EID: 2942560774     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.02.004     Document Type: Article

References (85)

1. Ott D.E. Potential roles of cellular proteins in HIV-1. Rev. Med. Virol. 12:2002;359-374
2. Pelchen-Matthews A., Kramer B., Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162:2003;443-455
3. Hoxie J.A., Fitzharris T.P., Youngbar P.R., Matthews D.M., Rackowski J.L., Radka S.F. Nonrandom association of cellular antigens with HTLV-III virions. Hum. Immunol. 18:1987;39-52
4. Arthur L.O., Bess J.W. Jr., Sowder R.C. II, Benveniste R.E., Mann D.L., Chermann J.C., Henderson L.E. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science. 258:1992;1935-1938
5. Rossio J.L., Bess J. Jr., Henderson L.E., Cresswell P., Arthur L.O. HLA class II on HIV particles is functional in superantigen presentation to human T cells: implications for HIV pathogenesis. AIDS Res. Hum. Retroviruses. 11:1995;1433-1439
6. Castilletti C., Capobianchi M.R., Fais S., et al. HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res. Hum. Retroviruses. 11:1995;547-553
7. Cantin R., Fortin J.F., Lamontagne G., Tremblay M. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood. 90:1997;1091-1100
8. Cantin R., Fortin J.F., Lamontagne G., Tremblay M. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 71:1997;1922-1930
9. Hildreth J.E., Orentas R.J. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science. 244:1989;1075-1078
10. Orentas R.J., Hildreth J.E. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retroviruses. 9:1993;1157-1165
11. Capobianchi M.R., Fais S., Castilletti C., Gentile M., Ameglio F., Dianzani F. A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J. Infect. Dis. 169:1994;886-889
12. Fortin J.F., Cantin R., Lamontagne G., Tremblay M. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71:1997;3588-3596
13. Fortin J.F., Cantin R., Tremblay M.J. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J. Virol. 72:1998;2105-2112
14. Frank I., Kacani L., Stoiber H., Stossel H., Spruth M., Steindl F., Romani N., Dierich M.P. Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious. J. Virol. 73:1999;3449-3454
15. Esser M.T., Graham D.R., Coren L.V., Trubey C.M., Bess J.W. Jr., Arthur L.O., Ott D.E., Lifson J.D. Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation. J. Virol. 75:2001;6173-6182
16. Bounou S., Dumais N., Tremblay M.J. Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B-and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription. J. Biol. Chem. 276:2001;6359-6369
17. Giguere J.F., Paquette J.S., Bounou S., Cantin R., Tremblay M.J. New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1. J. Immunol. 169:2002;2762-2771
18. Roberts B.D., Butera S.T. Host protein incorporation is conserved among diverse HIV-1 subtypes. AIDS. 13:1999;425-427
19. Lawn S.D., Roberts B.D., Griffin G.E., Folks T.M., Butera S.T. Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection. J. Virol. 74:2000;139-145
20. Tremblay M.J., Fortin J.F., Cantin R. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today. 19:1998;346-351
21. Ko H.S., Fu S.M., Winchester R.J., Yu D.T., Kunkel H.G. Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen-and antigen-activated T cells. J. Exp. Med. 150:1979;246-255
22. Reinherz E.L., Kung P.C., Pesando J.M., Ritz J., Goldstein G., Schlossman S.F. Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J. Exp. Med. 150:1979;1472-1482
23. Yu D.T., Winchester R.J., Fu S.M., Gibofsky A., Ko H.S., Kunkel H.G. Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J. Exp. Med. 151:1980;91-100
24. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434
25. Paquette J.S., Fortin J.F., Blanchard L., Tremblay M.J. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J. Virol. 72:1998;9329-9336
26. Bounou S., Leclerc J.E., Tremblay M.J. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J. Virol. 76:2002;1004-1014
27. Rizzuto C.D., Sodroski J.G. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. J. Virol. 71:1997;4847-4851
28. Fortin J.F., Cantin R., Bergeron M.G., Tremblay M.J. Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization. Virology. 268:2000;493-503
29. Freeman G.J., Freedman A.S., Segil J.M., Lee G., Whitman J.F., Nadler L.M. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:1989;2714-2722
30. Azuma M., Yssel H., Phillips J.H., Spits H., Lanier L.L. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:1993;845-850
31. Wolthers K.C., Otto S.A., Lens S.M., Kolbach D.N., van Lier R.A., Miedema F., Meyaard L. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells. Eur. J. Immunol. 26:1996;1700-1706
32. Foy T.M., Aruffo A., Bajorath J., Buhlmann J.E., Noelle R.J. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol. 14:1996;591-617
33. Clark L.B., Foy T.M., Noelle R.J. CD40 and its ligand. Adv. Immunol. 63:1996;43-78
34. Grewal I.S., Flavell R.A. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol. Today. 17:1996;410-414
35. Stout R.D., Suttles J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today. 17:1996;487-492
36. Clark E.A. CD40: a cytokine receptor in search of a ligand. Tissue Antigens. 36:1990;33-36
37. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., Spriggs M.K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:1993;669-674
38. Ware C.F., Crowe P.D., Vanarsdale T.L., Andrews J.L., Grayson M.H., Jerzy R., Smith C.A., Goodwin R.G. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J. Immunol. 147:1991;4229-4238
39. Armitage R.J., Tough T.W., Macduff B.M., Fanslow W.C., Spriggs M.K., Ramsdell F., Alderson M.R. CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23:1993;2326-2331
40. Fanslow W.C., Clifford K.N., Seaman M., Alderson M.R., Spriggs M.K., Armitage R.J., Ramsdell F. Recombinant CD40 ligand exerts potent biologic effects on T cells. J. Immunol. 152:1994;4262-4269
41. Vyth-Dreese F.A., Dellemijn T.A., van Oostveen J.W., Feltkamp C.A., Hekman A. Functional expression of adhesion receptors and costimulatory molecules by fresh and immortalized B-cell non-Hodgkin's lymphoma cells. Blood. 85:1995;2802-2812
42. Armitage R.J., Fanslow W.C., Strockbine L., et al. Molecular and biological characterization of a murine ligand for CD40. Nature. 357:1992;80-82
43. Roy M., Waldschmidt T., Aruffo A., Ledbetter J.A., Noelle R.J. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 151:1993;2497-2510
44. Cantin R., Martin G., Tremblay M.J. A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source. J. Gen. Virol. 82:2001;2979-2987
45. Tenner-Racz K., Racz P., Dietrich M., Kern P. Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet. 1:1985;105-106
46. Pantaleo G., Graziosi C., Butini L., Pizzo P.A., Schnittman S.M., Kotler D.P., Fauci A.S. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 88:1991;9838-9842
47. Fox C.H., Tenner-Racz K., Racz P., Firpo A., Pizzo P.A., Fauci A.S. Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J. Infect. Dis. 164:1991;1051-1057
48. Spiegel H., Herbst H., Niedobitek G., Foss H.D., Stein H. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am. J. Pathol. 140:1992;15-22
49. Pantaleo G., Graziosi C., Demarest J.F., et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 362:1993;355-358
50. Frankel S.S., Wenig B.M., Burke A.P., et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science. 272:1996;115-117
51. Glushakova S., Baibakov B., Margolis L.B., Zimmerberg J. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat. Med. 1:1995;1320-1322
52. Charron D.J., McDevitt H.O. Analysis of HLA-D region-associated molecules with monoclonal antibody. Proc. Natl. Acad. Sci. U. S. A. 76:1979;6567-6571
53. Chirathaworn C., Kohlmeier J.E., Tibbetts S.A., Rumsey L.M., Chan M.A., Benedict S.H. Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation. J. Immunol. 168:2002;5530-5537
54. Engel P., Gribben J.G., Freeman G.J., et al. The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen. Blood. 84:1994;1402-1407
55. Tenner-Racz K., Racz P., Gluckman J.C., Popovic M. Cell-free HIV in lymph nodes of patients with AIDS and generalized lymphadenopathy. N. Engl. J. Med. 318:1988;49-50
56. Tenner-Racz K., Racz P., Schmidt H., Dietrich M., Kern P., Louie A., Gartner S., Popovic M. Immunohistochemical, electron microscopic and in situ hybridization evidence for the involvement of lymphatics in the spread of HIV-1. AIDS. 2:1988;299-309
57. Parmentier H.K., van Wichen D., Sie-Go D.M., Goudsmit J., Borleffs J.C., Schuurman H.J. HIV-1 infection and virus production in follicular dendritic cells in lymph nodes. A case report, with analysis of isolated follicular dendritic cells. Am. J. Pathol. 137:1990;247-251
58. Embretson J., Zupancic M., Ribas J.L., Burke A., Racz P., Tenner-Racz K., Haase A.T. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 362:1993;359-362
59. Haase A.T., Henry K., Zupancic M., et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science. 274:1996;985-989
60. Carpen O., Pallai P., Staunton D.E., Springer T.A. Association of intercellular adhesion molecule-1 (ICAM-1) with actin-containing cytoskeleton and alpha-actinin. J. Cell Biol. 118:1992;1223-1234
61. Heiska L., Kantor C., Parr T., Critchley D.R., Vilja P., Gahmberg C.G., Carpen O. Binding of the cytoplasmic domain of intercellular adhesion molecule-2 (ICAM-2) to alpha-actinin. J. Biol. Chem. 271:1996;26214-26219
62. Rey O., Canon J., Krogstad P. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology. 220:1996;530-534
63. Liu B., Dai R., Tian C.J., Dawson L., Gorelick R., Yu X.F. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J. Virol. 73:1999;2901-2908
64. Frank I., Stoiber H., Godar S., Stockinger H., Steindl F., Katinger H.W., Dierich M.P. Acquisition of host cell-surface-derived molecules by HIV-1. AIDS. 10:1996;1611-1620
65. Lee B.S., Rust N.A., McMichael A.J., McDevitt H.O. HLA-DR2 subtypes form an additional supertypic family of DR beta alleles. Proc. Natl. Acad. Sci. U. S. A. 84:1987;4591-4595
66. Kochli C., Wendland T., Frutig K., Grunow R., Merlin S., Pichler W.J. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals. Immunol. Lett. 65:1999;197-201
67. Marodon G., Landau N.R., Posnett D.N. Altered expression of CD4, CD54, CD62L, and CCR5 in primary lymphocytes productively infected with the human immunodeficiency virus. AIDS Res. Hum. Retroviruses. 15:1999;161-171
68. Aries S.P., Schaaf B., Hansen F., Weyrich K., Kurowski V., Dennin R., Dalhoff K. Expression of complement receptors and regulatory proteins on alveolar CD4+ lymphocytes from human immunodeficiency virus-1 infected individuals. Eur. Respir. J. 10:1997;1736-1741
69. McIlroy D., Autran B., Clauvel J.P., Oksenhendler E., Debre P., Hosmalin A. Low CD83, but normal MHC class II and costimulatory molecule expression, on spleen dendritic cells from HIV+ patients. AIDS Res. Hum. Retroviruses. 14:1998;505-513
70. Casamayor-Palleja M., Khan M., MacLennan I.C. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J. Exp. Med. 181:1995;1293-1301
71. Brugnoni D., Prati E., Airo P., Castelli F., Cattaneo R. The ability of CD4+ cells from HIV+ individuals to express CD40 ligand after in vitro stimulation is not impaired. Clin. Immunol. Immunopathol. 74:1995;112-114
72. Chirmule N., McCloskey T.W., Hu R., Kalyanaraman V.S., Pahwa S. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J. Immunol. 155:1995;917-924
73. Wolthers K.C., Otto S.A., Lens S.M., Van Lier R.A., Miedema F., Meyaard L. Functional B cell abnormalities in HIV type 1 infection: role of CD40L and CD70. AIDS Res. Hum. Retroviruses. 13:1997;1023-1029
74. Vanham G., Penne L., Devalck J., Kestens L., Colebunders R., Bosmans E., Thielemans K., Ceuppens J.L. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin. Exp. Immunol. 117:1999;335-342
75. Sousa A.E., Chaves A.F., Doroana M., Antunes F., Victorino R.M. Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery. Clin. Exp. Immunol. 116:1999;307-315
76. Kornbluth R.S. The emerging role of CD40 ligand in HIV infection. J. Leukocyte Biol. 68:2000;373-382
77. Kornbluth R.S. An expanding role for CD40L and other tumor necrosis factor superfamily ligands in HIV infection. J. Hematother. Stem Cell Res. 11:2002;787-801
78. Subauste C.S., Wessendarp M., Smulian A.G., Frame P.T. Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection. J. Infect. Dis. 183:2001;1722-1731
79. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74:2000;3264-3272
80. Ono A., Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U. S. A. 98:2001;13925-13930
81. Anderson H.A., Hiltbold E.M., Roche P.A. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1:2000;156-162
82. Kaykas A., Worringer K., Sugden B. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J. 20:2001;2641-2654
83. Tilghman R.W., Hoover R.L. E-selectin and ICAM-1 are incorporated into detergent-insoluble membrane domains following clustering in endothelial cells. FEBS Lett. 525:2002;83-87
84. Huby R.D., Dearman R.J., Kimber I. Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J. Biol. Chem. 274:1999;22591-22596
85. Huby R., Chowdhury F., Lombardi G. Rafts for antigen presentation? Nat. Immunol. 2:2001;3